Patient with on-x mitral valve replacement (mvr) presented with valve thrombosis, cardiac failure, moderate rheumatic aortic regurgitation, and nyha class ii-iii.Patient is (b)(6), is known to be non-compliant with anticoagulation therapy.Re-operation performed, re-do mvr due to stuck mitral prosthesis (posterior leaflet).Aortic valve replacement also done.Intra-operatively, surgeon confirmed thrombus on the mitral valve.Patient recovered from the surgery.Valve thrombosis is by definition in the aats/sts guidelines a valve-related event and is therefore reportable.Valve thrombosis is an expected adverse event, as defined in the objective performance criteria in fda heart valve guidance, and iso 5840, and this occurrence is well-within expected rate.Correction of the event required re-operation, classified as a "serious injury".Therefore, it is reportable as an mdr.
|